Your browser doesn't support javascript.
loading
Design, synthesis and evaluation of novel norfloxacin analogs as potent anticancer and antioxidant agents.
Qurban, Faraz; Shahzad, Sohail Anjum; Khaskheli, Muhammad Saleh; Khan, Shafi Ullah; Khan, Shujaat Ali; Rauf, Waqar; Islam, Shamsul; Mannan, Abdul.
Afiliação
  • Qurban F; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, 22060, Pakistan.
  • Shahzad SA; Institute of Pharmaceutical Sciences, Peoples University of Medical & Health Sciences for Women, Nawabshah - Shaheed Benazirabad, Sindh, 67480, Pakistan.
  • Khaskheli MS; Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, 22060, Pakistan.
  • Khan SU; Department of Anesthesiology, Peoples University of Medical & Health Sciences for Women, Nawab Shah - Shaheed Benazirabad, Sindh, 67480, Pakistan.
  • Khan SA; Normandie University, UNICAEN, INSERM U1086 "ANTICIPE" (Interdisciplinary Research Unit for Cancers Prevention & Treatment), Centre François Baclesse, 3 avenue Général Harris, Caen, 14000, France.
  • Rauf W; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, 22060, Pakistan.
  • Islam S; Pakistan Institute of Engineering & Applied Sciences, Health Biotechnology Division, National Institute for Biotechnology & Genetic Engineering (NIBGE-C, PIEAS), Faisalabad, 38000, Pakistan.
  • Mannan A; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, 22060, Pakistan.
Future Med Chem ; 16(17): 1777-1789, 2024.
Article em En | MEDLINE | ID: mdl-39115052
ABSTRACT

Aim:

To synthesize a novel series of norfloxacin analogs and to evaluate biological activity.

Methodology:

Novel norfloxacin analogs were synthesized and characterized by NMR and mass spectrometry. Antiproliferative and antioxidant properties were studied.

Results:

Compound 2f was the most potent against HeLa cell-line with 100% inhibition of cell viability IC50 = 3.1 ± 0.2 µM. All compounds exhibit moderate to excellent antioxidant properties. Docking study demonstrates higher binding affinity of compounds with respective anticancer (B-cell lymphoma-2) and (tyrosinase) antioxidant targets. In silico absorption, distribution, metabolism and excretion profile of compounds proves all synthesized compounds follow Lipinski's rule of drug likeness, non toxic and possess passive gastrointestinal absorption.

Conclusion:

The biological profile suggest that the synthesized norfloxacin analogs can be a novel scaffold for future anticancer drug development.
[Box see text].
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Norfloxacino / Proliferação de Células / Simulação de Acoplamento Molecular / Antineoplásicos / Antioxidantes Limite: Humans Idioma: En Revista: Future Med Chem Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Paquistão País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Norfloxacino / Proliferação de Células / Simulação de Acoplamento Molecular / Antineoplásicos / Antioxidantes Limite: Humans Idioma: En Revista: Future Med Chem Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Paquistão País de publicação: Reino Unido